Blog
Are You Looking for a High-Growth Dividend Stock?
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is
Why U.S. Bancorp (USB) is a Top Dividend Stock for Your Portfolio
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is
Why SB Financial Group, Inc. (SBFG) is a Great Dividend Stock Right Now
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your
NatWest Group (NWG) is a Top Dividend Stock Right Now: Should You Buy?
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is
Why Mercantile Bank (MBWM) is a Great Dividend Stock Right Now
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from
1st Source (SRCE) Could Be a Great Choice
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is
Why State Street Corporation (STT) is a Great Dividend Stock Right Now
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is
ASML Holding Q3 Earnings Beat Estimates, Revenues Rise Y/Y
ASML Holding (ASML) reported third-quarter 2025 earnings of €5.48 per share, which increased 3.8% year over year. Converted to USD, ASML’s third-quarter 2025 earnings came at $6.41 per share, which
AYI or DUOL: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Technology Services sector have probably already heard of Acuity (AYI) and Duolingo, Inc. (DUOL). But which of these two companies is the best option for
CTSH vs. INFY: Which Stock Is the Better Value Option?
Investors interested in stocks from the Computers - IT Services sector have probably already heard of Cognizant (CTSH) and Infosys (INFY). But which of these two stocks presents investors with the
PENN vs. RRR: Which Stock Is the Better Value Option?
Investors interested in stocks from the Gaming sector have probably already heard of PENN Entertainment (PENN) and Red Rock Resorts (RRR). But which of these two stocks presents investors with the
ALL or WRB: Which Is the Better Value Stock Right Now?
Investors interested in Insurance - Property and Casualty stocks are likely familiar with Allstate (ALL) and W.R. Berkley (WRB). But which of these two stocks presents investors with the better
AOS or KNYJY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Manufacturing - Electronics sector have probably already heard of A.O. Smith (AOS) and Kone Oyj Unsponsored ADR (KNYJY). But which of these two stocks offers
INCY or ARGX: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and argenex SE (ARGX). But which of these two companies is the best option for those looking
JHG vs. KKR: Which Stock Is the Better Value Option?
Investors looking for stocks in the Financial - Investment Management sector might want to consider either Janus Henderson Group plc (JHG) or KKR & Co. Inc. (KKR). But which of these two stocks
SMFG or NABZY: Which Is the Better Value Stock Right Now?
Investors with an interest in Banks - Foreign stocks have likely encountered both Sumitomo Mitsui (SMFG) and National Australia Bank Ltd. (NABZY). But which of these two stocks offers value
PepsiCo Leans on Pricing Power: Is Volume Decline a Growing Risk?
PepsiCo, Inc. PEP delivered nearly 3% reported net revenue growth in the third quarter of 2025, driven primarily by its pricing power and portfolio reshaping initiatives. While price increases and
2 Construction & Mining Equipment Stocks to Watch Amid Industry Woes
Travelers Q3 Earnings Surpass Estimates on Solid Underwriting
The Travelers Companies TRV reported third-quarter 2025 core income of $8.14 per share, which beat the Zacks Consensus Estimate by 35.4%. The bottom line increased 55% year over year.The bottom line
Can Mastercard & U.S. Bank Simplify the Subscription Overload?
By partnering with U.S. Bank, Mastercard Incorporated MA is strengthening its role as a digital partner for banks by launching a new subscription management tool for U.S. Bank credit cardholders
Is Visa Direct the Catalyst for a Cashless Tipping Revolution?
In a bold move toward reshaping how tipped employees are paid, Visa Inc. V has teamed up with StopOn, along with Astra, which provides the payment technology infrastructure to power real-time
Core Laboratories to Post Q3 Earnings: Key Metrics to Watch
Core Laboratories Inc. CLB is set to release third-quarter 2025 results on Oct. 22, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of 19
3 AgTech & Food Innovation Stocks Poised for Long-Term Gains
An updated edition of the July 9, 2025, article.The agricultural and food industries are going through a new phase of transformation, driven by technology, sustainability and changing consumer
5 Low Price-to-Sales Picks for Investors Seeking Growth at a Bargain
Investing in stocks based on valuation metrics is a proven strategy for identifying opportunities with strong upside potential. While the price-to-earnings (P/E) ratio is a popular tool for gauging
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
Viatris VTRS announced the acquisition of Tokyo-based Aculys Pharma, a clinical-stage biopharmaceutical company specializing in neurological therapies. The deal grants Viatris the rights to develop


